Keep Me Logged In
CNBC's Meg Tirrell talks to the CEO of Global Blood Therapeutics, which has been hit today after disappointing data from its new sickle cell treatment. CEO Ted Love explains what's next for the company.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2018 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by